Civic Data
FDA RecallsUSDA RecallsAbout

FDA Recalls

  • Food recalls
  • Drug recalls
  • Device recalls

USDA Recalls

  • All USDA recalls
  • Poultry recalls
  • Meat recalls
  • Egg recalls

About

  • About us
  • FDA guides
  • USDA guides
  • Data sources
  • Privacy policy

Data

  • OpenFDA API
  • USDA FSIS

© 2026Civic Data · Data sourced from OpenFDA and USDA FSIS · Not affiliated with the U.S. Food and Drug Administration or the U.S. Department of Agriculture · Always verify against official sources before acting

  1. FDA Recalls
  2. ›Drug Recalls

FDA Drug Recalls

Recalls of prescription drugs, over-the-counter medications, and compounded pharmaceuticals.

Classification
AllClass IClass IIClass III
Status
AllOngoingCompletedTerminated
Date
All timePast 30 daysPast 12 months

Showing 16341–16360 of 17,860 recalls

Class IIOngoing

Acepromazine 25 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

May 29, 2013 · DrugView details →
Class IIOngoing

Oxytocin 20 units/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

May 29, 2013 · DrugView details →
Class IIOngoing

Medroxyprogesterone 150 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

May 29, 2013 · DrugView details →
Class IIOngoing

Estradiol Cypionate 10 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

May 29, 2013 · DrugView details →
Class IIOngoing

Detomidine 10 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

May 29, 2013 · DrugView details →
Class IIOngoing

Diphenhydramine 50 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

May 29, 2013 · DrugView details →
Class IIOngoing

Phentolamine 20 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

May 29, 2013 · DrugView details →
Class IIOngoing

Cal-Phos 1000 Injection, compounded by Olympia Pharmacy, Orlando, FL

Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

May 29, 2013 · DrugView details →
Class IIOngoing

Adenosine-Mono-Phosphate Injection, 200 mg/ml, compounded by Olympia Pharmacy, Orlando, FL

Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

May 29, 2013 · DrugView details →
Class IIOngoing

Guanabenz 8 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

May 29, 2013 · DrugView details →
Class IIOngoing

Methylcobalamin 25 mg/ml Inj and 5000 mcg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

May 29, 2013 · DrugView details →
Class IIOngoing

Bi mix, compounded by Olympia Pharmacy, Orlando, FL

Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

May 29, 2013 · DrugView details →
Class IIOngoing

Fluphenazine 25 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

May 29, 2013 · DrugView details →
Class IIOngoing

Sodium Iodide 20% Injection, compounded by Olympia Pharmacy, Orlando, FL

Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

May 29, 2013 · DrugView details →
Class IIOngoing

Dextrose 50% Solution, compounded by Olympia Pharmacy, Orlando, FL

Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

May 29, 2013 · DrugView details →
Class IIOngoing

Phenobarbital 62. 5mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

May 29, 2013 · DrugView details →
Class IIOngoing

Gentamicin 300 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

May 29, 2013 · DrugView details →
Class IIOngoing

HCG 125iu/0.25ml (550iu/ml), 3500iu and 10,000iu, compounded by Olympia Pharmacy, Orlando, FL

Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

May 29, 2013 · DrugView details →
Class IIOngoing

Pento-Gluc 200 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

May 29, 2013 · DrugView details →
Class IIOngoing

Stanozolol (50 mg/ml and 100 mg/ml) Injection, compounded by Olympia Pharmacy, Orlando, FL

Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

May 29, 2013 · DrugView details →
← PreviousPage 818 of 893Next →